AGC
SNY icon

Aspen Grove Capital’s Sanofi SNY Stock Holding History

Aspen Grove Capital’s Portfolio SNY Stock Details SNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$290K Sell
6,792
-933
-12% -$41.7K 0.04% 164
2026
Q1 		$372K Buy
7,725
+87
+1% +$4.06K 0.07% 116
2025
Q4 		$370K Sell
7,638
-1
-0% -$50 0.06% 117
2025
Q3 		$361K Sell
7,639
-3,507
-31% -$169K 0.06% 121
2025
Q2 		$538K Buy
11,146
+115
+1% +$5.88K 0.09% 105
2025
Q1 		$612K Buy
11,031
+2,108
+24% +$114K 0.12% 98
2024
Q4 		$430K Sell
8,923
-1,460
-14% -$74.2K 0.09% 114
2024
Q3 		$598K Hold
10,383
– – 0.13% 89
2024
Q2 		$504K Buy
10,383
+319
+3% +$15.4K 0.12% 101
2024
Q1 		$489K Buy
10,064
+57
+0.6% +$2.78K 0.14% 95
2023
Q4 		$504K Sell
10,007
-186
-2% -$9.1K 0.15% 87
2023
Q3 		$547K Sell
10,193
-87
-0.8% -$4.64K 0.2% 82
2023
Q2 		$554K Sell
10,280
-56
-0.5% -$3.01K 0.18% 105
2023
Q1 		$562K Buy
10,336
+696
+7% +$33.9K 0.25% 83
2022
Q4 		$467K Buy
+9,640
New +$423K 0.22% 84

Other funds holding SNY

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
MIP
Mondrian Investment Partners London, United Kingdom $6.48B AUM 18.36% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.3B AUM 23.11% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Aspen Grove Capital's SNY Position: Q2 2026 in Review

Aspen Grove Capital reduced its Sanofi (SNY) stake by 12% in Q2 2026, selling an estimated $41.7K and leaving 6,792 shares worth $290K. The position accounts for 0.04% of the portfolio, ranked #164.

Aspen Grove Capital first reported a position in SNY in Q4 2022 and has held it in 15 quarters since. The position peaked at $612K in Q1 2025. 714 funds tracked by Wall St. Rank hold SNY as of Q2 2026.

  • Aspen Grove Capital held 6,792 shares of Sanofi worth $290K as of Q2 2026.
  • Aspen Grove Capital sold 933 Sanofi shares in Q2 2026, an estimated $41.7K.
  • Sanofi made up 0.04% of Aspen Grove Capital's portfolio in Q2 2026, its #164 holding.
  • Aspen Grove Capital first reported a position in Sanofi in Q4 2022 and has held it in 15 quarters since.
  • Aspen Grove Capital's Sanofi position peaked at $612K in Q1 2025.
  • 714 funds tracked by Wall St. Rank held Sanofi as of Q2 2026.

Based on Aspen Grove Capital's 13F filing for Q2 2026, filed 14 Aug 2026.